“The field of Molecular imaging is growing and changing rapidly and with the Society of Nuclear Medicine recently rebranding to include Molecular in their name, the molecular industry is investing money and resources to drive the molecular field forward. New beta amyloid PET tracers that have received FDA clearance point to signs of growth in our industry and along with recent developments in the field of cardiac imaging, point to some exciting and promising time for all of those involved. MIS is poised to be a part of this exciting growth.”
Sunil R. Selvin is a results-oriented healthcare executive with extensive expertise in Operations Management and Clinical Education. Sunil is a Certified Nuclear Medicine Technologist with over 15 years of experience in Nuclear Medicine, including Nuclear Cardiology, Oncologic PET, PET/CT and Cardiac PET and PET/CT. Currently Sunil serves as the Vice President of Operations and Clinical Education at Molecular Imaging Services Inc., where he manages the day-to-day operations of the MIS imaging centers and is responsible for planning and directing clinical education activities to create value for MIS staff and physicians. Prior to Joining MIS Sunil worked for Eastern Isotopes, Inc., and later IBA Molecular North America. During his tenure, Sunil was instrumental in developing and delivering innovative programs including “Daily Use Rubidium”. Sunil was directly responsible in implementing the daily use Rubidium service out of multiple IBA pharmacies. Sunil has extensive experience starting and adding Cardiac PET service in both hospital and outpatient settings and has helped start up over 50 sites, including Memorial Sloan Kettering, Johns Hopkins Medstar Washington Hospital Center to name a few.
